Raynaud's phenomenon triggered by the vasopressin V2 receptor antagonist tolvaptan in a patient with autosomal dominant polycystic kidney disease and Sjögren's syndrome
Clin Kidney J. 2021 Dec 9;15(4):827-828.
doi: 10.1093/ckj/sfab260.
eCollection 2022 Apr.